Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
Buod ng balita
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
Subaybayan ang mga pinakabagong balita mula sa mapagkakatiwalaang publisher na may maiikling buod. Buksan ang orihinal na link para sa detalye.